BioSpace News Archive

Premia Spine, a medical technology company changing the way debilitating chronic leg and back pain is treated, today announced that a single-center study evaluating its TOPS™ System for lumbar spinal stenosis and degenerative spondylolisthesis has been published in the journal Operative Neurosurgery.

2seventy bio, Inc. (Nasdaq: TSVT) today announced plans to initiate the KarMMa-9 study to evaluate Abecma (idecabtagene vicleucel) in newly diagnosed multiple myeloma patients who have suboptimal response to transplant.

NEXGEL, Inc. announced that Adam Levy, CEO, will present at the H.C. Wainwright 24th Annual Global Investment Conference being held on September 12th – 14th at the Lotte New York Palace Hotel in New York, NY.

Voyager Therapeutics, Inc. announced the appointment of Peter Pfreundschuh as Chief Financial Officer ; Todd Carter, Ph.D., as Chief Scientific Officer ; and Trista Morrison as Senior Vice President of Corporate Affairs.

Science and Medicine Group Inc. (SMG), a data intelligence company providing actionable insights about hard-to-reach audiences in life sciences and healthcare, today announced that it has acquired the assets of Amplion Inc., an innovator in AI-powered data intelligence for life science marketing and sales teams seeking to identify business opportunities and accelerate sales growth.

Accuray Incorporated announced the company is joining forces with Genolier Innovation Hub, a fully-owned subsidiary of AEVIS VICTORIA SA, in support of a unique new approach to improving patient care.

Syros Pharmaceuticals announced that its Chief Executive Officer, Nancy Simonian, M.D., will present a corporate overview at the H.C. Wainwright 24th Annual Global Investment Conference.

Marinus Pharmaceuticals, Inc. announced that management will present and participate in the following investor conferences in September.

TRACON Pharmaceuticals, Inc. announced that Charles Theuer, M.D., Ph.D., President and Chief Executive Officer, will participate at the following upcoming investor conferences and provide a company overview.

Zenas BioPharma announced the appointment of Simon Lowry, M.D., as the company’s Chief Medical Officer.